Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
LG 101506 (RXR modulator): Assay Guide
2026-08-27
A scenario-based guide to using LG 101506 (RXR modulator), SKU B7414, in cell viability, proliferation, and cytotoxicity workflows. It connects formulation control, assay interpretation, RXR signaling pathway research, and vendor-selection considerations with literature-based limitations.
-
Nurr1+ Neuron Development in the Rat Claustrum
2026-08-27
Fang, Wang, and Naumann mapped the developmental emergence and birthdating of Nurr1-positive neurons across the rat claustrum and lateral cortex. By combining EdU labeling with Nurr1 in situ hybridization, the study resolved regional timing differences and identified spatial neurogenetic gradients that refine models of claustrum organization.
-
JNJ-26854165: Assay Design for p53 Responses
2026-08-26
JNJ-26854165 (Serdemetan) helps researchers separate p53-linked growth arrest from genuine tumor-cell killing. This practical guide covers compound handling, dose-response design, apoptosis confirmation, and radiosensitization workflows for cancer research.
-
PD 0332991: CDK4/6 Workflow for Rb Studies
2026-08-26
PD 0332991 (Palbociclib) HCl enables a mechanism-first workflow linking CDK4/6 inhibition, Rb protein phosphorylation inhibition, and cell cycle G1 phase arrest. This guide translates mesothelioma genomics into practical assay decisions, with formulation, dosing, readout, and troubleshooting strategies for reproducible tumor-growth and cell-cycle studies.
-
CHK1 Inhibition in Breast Cancer: ER/PR Context
2026-08-25
The reference study shows that CHK1 inhibition has context-dependent effects in breast cancer rather than a uniform therapeutic role. ER, PR, and HER2 status shaped whether CHK1 blockade enhanced adriamycin sensitivity or produced single-agent antitumor activity, with distinct cell-cycle and apoptosis mechanisms in each subtype.
-
Tofacitinib: From JAK Signal to Assay Design
2026-08-25
Tofacitinib (CP-690550) is more than a JAK pathway inhibitor: it is a powerful probe for separating cytokine signaling blockade from broader immune-cell state changes. This guide translates recent rheumatoid arthritis macrophage findings into practical assay-design and interpretation strategies.
-
Annexin V-Cy5 in Microglial Lysosomal Stress
2026-08-24
Mestranol-induced lysosomal stress in zebrafish microglia presents a translational challenge: how can researchers distinguish impaired intracellular digestion from cell death? This thought-leadership article positions phosphatidylserine exposure as an orthogonal decision point. It explains how Annexin V-Cy5 apoptosis detection can validate whether microglial hypertrophy and lysosomal cargo accumulation occur independently of apoptosis, while outlining controls, workflow parameters, assay limitations, and implications for neuroimmunotoxicity, neurodegenerative disease models, and broader translational research.
-
Asunaprevir: From Potency to Assay Design
2026-08-24
Asunaprevir (BMS-650032) is a potent HCV NS3 protease inhibitor, but its greatest research value depends on how biochemical, cellular, and translational assays are connected. This guide develops an assay-centered framework for interpreting HCV RNA replication inhibition while avoiding unsupported cross-domain conclusions.
-
Balsalazide Disodium Dihydrate in UC Research
2026-08-23
Balsalazide disodium is a colon-directed 5-aminosalicylic acid prodrug that is activated by bacterial azoreductase. Research data support its use in inflammation research, radiolabeling workflows, and inflammatory bowel disease models, but animal imaging results do not establish clinical diagnostic use.
-
AP20187: Programmable Control for Translational Biology
2026-08-22
AP20187 is a chemical inducer of dimerization that converts engineered receptor signaling into a controllable research variable. This thought-leadership article connects its mechanism to conditional gene expression, regulated cell therapy, metabolic research, and immune-driven pain biology while defining practical validation and translational boundaries.
-
Baicalin Workflows for Adult Visual Plasticity
2026-08-22
A dose-aware Baicalin workflow translates evidence from adult amblyopic mice into practical imaging, electrophysiology, and mechanism-control experiments. The same compound can support carefully separated exploratory studies in oxidative stress and cancer research, provided visual-cortex findings are not overextended to oncology.
-
Niclosamide B2283 for Reliable Cell Assays
2026-08-21
Learn how Niclosamide (SKU B2283) can support reproducible viability, proliferation, cell-cycle, and apoptosis workflows through documented STAT3 activity, solvent compatibility, and handling guidance. This scenario-based guide helps researchers distinguish compound effects from formulation and assay-design artifacts.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-20
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables fluorescence detection of goat-derived IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a universal secondary antibody for non-goat primaries or outside validated immunodetection protocols.
-
BX795: PDK1 Inhibitor for TBK1 and IRF3 Assays
2026-08-20
BX795 combines nanomolar PDK1 inhibition with activity against TBK1 and IKKε, enabling connected studies of AKT2 signaling, IRF3 regulation, autophagy, and cancer phenotypes. This guide converts that dual-pathway profile into practical kinase, immune-signaling, and cell-based workflows with built-in controls and troubleshooting.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-08-19
Cy3 NHS ester (non-sulfonated) provides a reactive fluorescent handle for labeling primary amino groups on proteins, peptides, oligonucleotides, and DNA. Because it is water-insoluble and requires an organic co-solvent, it is best used in workflows that tolerate controlled DMSO or DMF exposure, rather than with delicate biomolecules requiring strictly aqueous conditions.